Cargando…
Is N-methylacetazolamide a possible new therapy against ischemia-reperfusion injury?
The increase of intracellular Ca(2+) concentration, produced principally by its influx through the L-type Ca(2+) channels, is one of the major contributors to the ischemia-reperfusion injury. The inhibition of those channels in different experimental models was effective to ameliorate the post-ische...
Autores principales: | Pardo, Alejandro Ciocci, Díaz Zegarra, Leandro A., González Arbeláez, Luisa F., Aiello, Ernesto A., Mosca, Susana M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448815/ https://www.ncbi.nlm.nih.gov/pubmed/37637427 http://dx.doi.org/10.3389/fphar.2023.1223132 |
Ejemplares similares
-
Myocardial and mitochondrial effects of the anhydrase carbonic inhibitor ethoxzolamide in ischemia‐reperfusion
por: Ciocci Pardo, Alejandro, et al.
Publicado: (2021) -
The noncarbonic anhydrase inhibiting acetazolamide analog N-methylacetazolamide reduces the hypercapnic, but not hypoxic, ventilatory response
por: Teppema, Luc J, et al.
Publicado: (2015) -
Antioxidant Activity and Cardioprotective Effect of a Nonalcoholic Extract of Vaccinium meridionale Swartz during Ischemia-Reperfusion in Rats
por: Lopera, Yasmin E., et al.
Publicado: (2013) -
CaMKII‐dependent ryanodine receptor phosphorylation mediates sepsis‐induced cardiomyocyte apoptosis
por: Sepúlveda, Marisa, et al.
Publicado: (2020) -
c-Jun N-Terminal Kinases (JNKs) in Myocardial and Cerebral Ischemia/Reperfusion Injury
por: Shvedova, Maria, et al.
Publicado: (2018)